Update on Commercial Terms for the Proposed Merger with MAP
Filed with ASX ·
6ix is reading this filing.
Genetic Signatures Ltd. on 6ix
Earlier from Genetic Signatures
- Response to Media Speculation & BCAL letter to GSS
- GSS: Response to Media Speculation & BCAL letter to GSS
- Quarterly Activities/Appendix 4C Cash Flow Report
- GSS Investor Presentation - Proposed Merger with MAP
- Receipt of Section 249D Notice from BCAL Diagnostics
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures